PEAL Capital Group (“PEAL”) is pleased to announce it has acquired a majority shareholding in Derma Medical for an undisclosed sum. Led by Karen O’Mahony (Managing Partner) and Tara Mandal (Partner & COO), PEAL acquires controlling stakes in companies with established business models, well-developed products and services and corporate cultures that value diversity and inclusion. PEAL uses a hands-on, proactive approach to reposition its portfolio companies for accelerated revenue and margin growth.
The provider leading the cosmetic training market
At the forefront of non-surgical aesthetic treatments, Derma Medical equips medical professionals with recognized qualifications in non-invasive injectable cosmetic procedures. In an industry where science meets art, the Derma Medical courses bring new skills and techniques to medical practitioners across the globe.
Derma Medical has UK-wide training covering London, Birmingham, Manchester, and Edinburgh. It also attracts delegates through international training academies in Sydney, Brisbane, Melbourne, and Perth (Australia), Stockholm (Sweden) and Dubai (UAE).
Fortune projected that the global facial injectables market would grow from $4.77 billion in 2021 to $9.07 billion in 2028 at a CAGR of 9.6 percent. Derma Medical is a leading provider of training in this field. It provides recognized qualifications for medical professionals and those registered with professional statutory and regulatory bodies (PSRBs), such as the General Medical Council (GMC), Nursing and Midwifery Council (NMC), General Dental Council (GDC) and General Pharmaceutical Council (GPhC).
PEAL helps Derma Medical enter the next phase of growth
Derma Medical witnessed exceptional growth over the previous five years, but global expansion requires an injection of operational expertise. PEAL’s experience in repositioning companies, coupled with innovative thinking, will take it to the next level of growth.
PEAL Capital Group would like to thank PwC, Silicon Valley Bank, Rosetta Tax, Locke Lord, McCann FitzGerald, Waystone, SEI, Ince, Kroll & RWT Growth (who ably represented the vendors on this deal) for their support on this transaction. “It takes a village to raise a child.” It took the input of at least 100 dedicated professionals to close out this deal.
Karen O’Mahony, Founder and Managing Partner of PEAL, commented, “We are thrilled to partner with Dr. Zack Ally, Dr. Sanah Qasem and the talented, hardworking and innovative team. They have turned Derma Medical into the UK’s most reputable and recognized brand in aesthetic procedure training for medical professionals. PEAL invests in high-quality companies with diverse management teams, and this is perfectly exemplified in Derma Medical. Every PEAL deal begins with a 100-day plan, and the progress of this plan has already exceeded our expectations.”
Dr. Zack Ally, the founder of Derma Medical Group, added, “When my wife, Sanah Qasem, and I worked as junior NHS doctors, we wanted to find an outlet to earn an additional income whilst doing something exciting and creative. We attended courses in aesthetic medicine, but found they lacked that professional touch. As our reputations in aesthetic medicine grew, we started to teach our friends at the NHS more about the techniques and trademarks of this fascinating industry. That was how the Derma Medical training courses were born. We are delighted to work with PEAL to grow it into a global brand.”
Fox joins Derma Medical as Executive Chair
Joining the Derma Medical team as Executive Chair is Jennifer Fox. She has an extensive background in global hospitality, luxury branding, and leading executive teams. Previously, she was the International President of Fairmont Hotels and Resorts, CEO of the Millennium Group, and COO of IHG Europe. Ms. Fox, based in the new corporate headquarters in Portman House, London, is responsible for building out the organization structure.
Ms. Fox said, “This pioneering business provides fantastic career opportunities for medical professionals to enhance the lives and well-being of their patients through technological advances and artistic expression. I would like to recognize the incredible work and creativity of Dr. Zack and his team in building such a high-quality enterprise. I am delighted to lead this talented team to pursue the next level of innovation and international expansion.”
About Derma Medical
Derma Medical upholds the highest non-surgical cosmetic injectable training standards in line with the latest industry and Government guidelines. The training academy offers Botox and dermal filler training courses to medical professionals at home and abroad. Since the founding of the company in 2015, Dr. Zack Ally and Dr. Sanah Qasem have taught thousands of delegates on aesthetic medicine, an industry where science meets art. They were among the first training providers in the UK to offer the accredited level 7 qualification in cosmetic injectables, which Ofqual regulates. (www.dermamedical.co.uk)
About PEAL Capital Group
PEAL Capital Group was established in 2014 as an out-sourced general partner and advisory firm to family offices. It is a female-led firm with a strong, established 17-year track record in private equity investing. The team has over 65 years of combined experience in private equity, corporate finance, and operational management. PEAL launched its maiden fund in 2021.
Karen O’Mahony and Tara Mandal lead PEAL with the support of experienced finance professionals in both London and Dublin. PEAL leverages its resources, expertise and experience to bring portfolio companies to the next level of growth.
PEAL, founded and led by women, takes very different perspectives and approaches to deal-making to traditional private equity managers. With a core focus on value investing, PEAL applies a Diversity & Inclusion lens to all its investments, thereby ensuring that management teams reflect the society we live in and that all employees share financially in the success of our growth plans. (www.pealcapital.com)
For tips on how to win over private equity investors, read this on Lioness.